Literature DB >> 18638042

Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease.

M Koutouzis1, L S Rallidis, G Peros, A Nomikos, V Tzavara, C Barbatis, V Andrikopoulos, J Vassiliou, Z S Kyriakides.   

Abstract

INTRODUCTION: The levels of circulating proinflammatory cytokines may express the extent of the inflammatory response and their participation in plaque progression and rupture needs to be evaluated. We aimed to investigate differences in circulating levels of proinflammatory cytokines and in plaque infiltration by macrophages between patients undergoing carotid endarterectomy for symptomatic and asymptomatic carotid atherosclerotic disease.
METHODS: One hundred nineteen patients (91 men and 28 women; mean age 66 +/- 8 years; range 42-83 years) who underwent carotid endarterectomy for significant (>70%) carotid bifurcation stenosis were enrolled in this study. Patients were characterized as symptomatic (n = 62) or asymptomatic (n = 57) after neurological examination. Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), IL-1beta, serum amyloid A (SAA), and high-sensitivity C-reactive protein (hs-CRP) were evaluated. Macrophage infiltration of the plaque was assessed quantitatively from endarterectomy specimens using the monoclonal antibody CD68.
RESULTS: Serum IL-6 levels were significantly higher in patients with symptomatic compared with those with asymptomatic carotid disease (3.3 [2.0-6.5] pg/ml vs 2.5 [1.9-4.1] pg/ml, P = 0.02). TNF-alpha, IL-1beta, SAA, and hs-CRP levels did not differ significantly between the two groups. Symptomatic patients had also more intense macrophage accumulation in the carotid plaque compared with asymptomatic patients (0.6 +/- 0.1% vs 0.4 +/- 0.1%, P < 0.001). Although there were correlations between the levels of the different inflammatory markers, there were no correlation between any of them and the extent of plaque macrophage infiltration.
CONCLUSION: Patients with symptomatic carotid atherosclerotic disease have elevated serum IL-6 levels compared with asymptomatic patients. Symptomatic patients have also more intense macrophage infiltration of the atherosclerotic plaque suggesting that inflammatory process may contribute to the destabilization of the carotid plaque.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638042     DOI: 10.1111/j.1600-0404.2008.01068.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study.

Authors:  Natalie Suder Egnot; Emma Barinas-Mitchell; Michael H Criqui; Matthew A Allison; Joachim H Ix; Nancy S Jenny; Christina L Wassel
Journal:  Thromb Res       Date:  2018-02-13       Impact factor: 3.944

2.  IL-6-targeted ultrasmall superparamagnetic iron oxide nanoparticles for optimized MRI detection of atherosclerotic vulnerable plaques in rabbits.

Authors:  Huaqiang Mo; Chenxing Fu; Zhiye Wu; Peng Liu; Zhibo Wen; Qingqing Hong; Yanbin Cai; Gongxin Li
Journal:  RSC Adv       Date:  2020-04-17       Impact factor: 3.361

Review 3.  Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis.

Authors:  Enrico Ammirati; Francesco Moroni; Giuseppe Danilo Norata; Marco Magnoni; Paolo G Camici
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

4.  Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis.

Authors:  Hanna Pawluk; Grzegorz Grześk; Renata Kołodziejska; Mariusz Kozakiewicz; Alina Woźniak; Elżbieta Grzechowiak; Maciej Szumny; Piotr Sobolewski; Leszek Bieniaszewski; Grzegorz Kozera
Journal:  Clin Interv Aging       Date:  2020-08-06       Impact factor: 4.458

5.  Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.

Authors:  Louise Ziegler; Jasmin Lundqvist; Kristian Dreij; Håkan Wallén; Ulf de Faire; Gabrielle Paulsson-Berne; Ulf Hedin; Ljubica Matic; Bruna Gigante
Journal:  Vasc Med       Date:  2020-12-22       Impact factor: 3.239

6.  Inflammatory markers in patients with internal carotid artery stenosis.

Authors:  Przemysław Puz; Anetta Lasek-Bal; Damian Ziaja; Zofia Kazibutowska; Krzysztof Ziaja
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

7.  Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis.

Authors:  Piotr Musialek; Wieslawa Tracz; Lukasz Tekieli; Piotr Pieniazek; Anna Kablak-Ziembicka; Tadeusz Przewlocki; Ewa Stepien; Przemyslaw Kapusta; Rafal Motyl; Jakub Stepniewski; Anetta Undas; Piotr Podolec
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

8.  Risk prediction model of dyslipidaemia over a 5-year period based on the Taiwan MJ health check-up longitudinal database.

Authors:  Xinghua Yang; Chaonan Xu; Yunfeng Wang; Chunkeng Cao; Qiushan Tao; Siyan Zhan; Feng Sun
Journal:  Lipids Health Dis       Date:  2018-11-17       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.